transaction Currently, the Company encounters the situation of the lack of financial liquidity and the cash flow for the business operation, as the Company has continuous accumulated loss. Thus, the Company
products in December 2016 whereas no any policy to be incurred in this year. In addition public hospitals, major customers of the Company, have faced the liquidity problems; therefore, the Company has to
(EBITDA / finance costs) decreased to 32x from 120x and debt to equity ratio increased to 0.44x from 0.13x. In respect of liquidity ratio in year 2018, average trade receivable day improved due to increase
. Liquidity In 2019, the Company had a net decrease of cash and cash equivalents of 375.5 million Baht, divided into cash flow details for each activity as follows: 2018 2019 Cash flow from operating activities
December 2016 Change Reason Liquidity Ratio (x) 7.88 8.56 (0.68) The decreases were attributable to the redemption of partial investment to support the expanding of Company’s business and dividend payment
compared to 2016. To maintain company liquidity, there บริษทั พาโตเคมอุีตสาหกรรม จ ากดั (มหาชน) PATO CHEMICAL INDUSTRY PUBLIC CO., LTD. Pato Building, 3388 New Petchburi Road, Bangkok 10310, Thailand Tel
2016 Change Reason Liquidity Ratio (x) 7.68 8.56 (0.88) The decreases were attributable to the redemption of partial investment to support the expanding of Company’s business and dividend payment. Quick
amounting to 954.0 million baht. The cash flow from financing gain was from the debenture issuance and cash received from capital increasing. The Company’s liquidity ratio is 2.72 times in 2017 compared with
increasing. The Company’s liquidity ratio is 2.72 times in 2017 compared with 0.55 in 2017. The Company’ extends the tenor of debt profile longer by using debentures. Forward Looking The Company will pursue